In this paper the Informed Consent Principle for sensitive information management is revisited under the perspective of ubiquitous and embedded computing and of personalized privacy. We claim that an Informed Fair Consent Principle, here proposed, takes into account privacy threats, pointed out in the paper, which may stem from some granted consent. Potential implementations of the fair personalized privacy are shortly discussed.
INTRODUCTION
Privacy has several meanings and does not always involve information. Here the focus is on information privacy, that is on the right of information owners to determine when, how and to what extent information about them is collected, stored, shared, processed, communicated to others and disseminated . It is nowadays well known that privacy, as well as security, has to face new challenges at every technological innovation which facilitates the dissemination of information (De Capitani and Samarati, 2006) . Besides technological novel open issues which arise because of the technological evolution, also traditional notions may need to be revisited because of novel technologies. This is the case for the consent notion, which is crucial for the privacy preservation. Privacy is context dependent at least in a twofold sense. It depends on local law, though privacy cannot be limited to compliance to law regulations (sometimes fragmented if not inconsistent (Applebaum et al., 1987) ), and on the application domain. Throughout this paper, the sanitary context is the considered application domain. Health related information is sensitive. Privacy preservation is a traditional issue in the sanitary context since the formulation of the Hippocratic Oath. Nowadays, the amount of sociosanitary and clinical data is dramatically increasing also because of ubiquitous and embedded computing. Worn and implanted devices, as utilized for instance in remote patient monitoring via sensors and RFID tag-reader technology (Solanas and CastellaRoca, 2008) , generate increasing quantities of data that will be made available to a growing number of applications in research, clinical audit, administration and marketing. Patients are the humans who can be considered as mobile embedded systems, due to the smart low-resource devices (digital assistants, health monitoring devices, pacemakers, etc.) they carry and on which they depend more or less seriously. Such devices communicate with back-end systems and data are gathered in databases or in centralized clinical data repositories (Fung et al., 2010) .
Socio-sanitary systems have been set up which may connect patients, caregivers, sanitary administrators, healthcare organizations, pharmacies, etc. Throughout any regional setting, segments of information are maintained by autonomous, networked clinical information sources having differing internal structures, database schemata and vocabularies to describe the notions they use. Such gathered data are often shared with users who need them for data mining tasks. Patient records are often released to an external medical center for information sharing. Health data sets are often released for, e.g., various statistics, research purposes, classifiers and education. In some cases publishers know in advance the kind of mining work that need to be performed on the released data, but in other cases they do not. In pervasive and cloud computing environments, the patient control on personal data looses its potential effectiveness once personal information is managed on servers located in a Country different from that where the patient lives. Thus the consents granted by patients have to be analyzed more deeply for what concerns the authorizations they may determine on information management. mation release is revisited. A privacy threat is singled out which derives from consents granted by patients and which has a social privacy impact. A Fair Consent Principle is proposed to overcome the underlined privacy problem and its effectiveness is discussed. The paper is structured into five sections besides Introduction and Conclusions. In Section 2, the informed consent for personal data publication is considered, exemplifying in the healthcare framework. In Section 3, the problem of the patient consent that concerns other individuals is addressed in the personalized privacy perspective. In Section 4, a Fair Consent Principle is proposed. In Section 5 fair personalized privacy is discussed taking into account both privacy protection and data utility issues. In Section 6 related work is mentioned. Consent from patients should be obtained before publishing personal information about them, whether or not patients can be identified, at a greater reason if there is any doubt about achieving complete anonymity. The various aspects that have been addressed in the published literature concerning patient consent for healthcare suggest that a consent freely given by someone with the mental ability to do so is an ongoing process (Royal College, 2011). Publication without consent is acceptable in some cases, e.g., if the patient is long dead and has no living relatives or if the patient is unable to give consent. Emergency situations may require forcing the privacy rules of the privacy policy in use. Anyway, disclosures without consent must always be legal and justifiable as necessary (for instance, in case there is a public interest or a serious unlawful act or a legal process).
INFORMED CONSENT

PERSONALIZED PRIVACY
Raw data gathered from embedded devices are organized as records (microdata) grouped as row tables, with columns as attributes. There are attribute classes: Identifiers (as complete names, social security numbers, passport numbers) that explicitly identify individuals; Quasi-identifiers (as postal codes, gender, age) that identify individuals once they are combined with other information; Sensitive Attributes (as disease, disability state, financial state, religion) and Non-Sensitive Attributes. Table 1 (a modified version of Table 3 in (Xiao and Tao, 2006) ) is a raw data table.
In Table 1 , 'sta.pneumonia', 'stre.pneumonia' and 'as.hemoph. A' stand for 'staphylococcus pneumonia', 'streptococcus pneumonia' and 'asymptomatic hemophilia A', respectively.
For the disclosure perspective, microdata undergo some anonymity process. Specifically, for achieving de-identification, Identifiers are replaced by numerical values more or less randomized. However, nowadays it is well known that by linking Quasi-identifiers in de-identified tables with some external data (somehow available) may determine re-identification. Then also Quasi-identifiers are somehow anonymized. Sensitive Attributes are unmodified.
Of the two disclosure types, namely identity dis- closure (i.e., discovering that a certain individual is included in a target table) and sensitive attribute disclosure (i.e., associating a sensitive attribute with individuals ), we here address the second one. Since privacy is not an all-or-nothing notion, it can be weak or strong and it makes sense to have privacy levels. Privacy is essentially personalized, as it has been pointed out in (Xiao and Tao, 2006) . A universal protection level may result as insufficient for some parties and excessive for others. What will cause offence strongly depends on individuals. To avoid undesired protection, a patient may be allowed to require a privacy protection under a taxonomy. In Table 2 with anonymized Identifiers, personalized generalizations have been performed on Quasi-identifiers and on Diagnosis attribute values. The taxonomy tree, labeled at nodes, for Sex is:
and for Age is: Table 2 mean that all patients have given their consent to allow releasing the true diagnosis for their diseases.
But 'asymptomatic hemophilia A' potentially allows association with more than one identifiable individual (not necessarily in the same table). An additional external knowledge about for instance Sarah's relatives allows the data recipient to know that they have the same disease, more or less seriously, Sarah has. Analogously, releasing data on an infectious disease does potentially compromise the privacy of individuals who live in close contact with the patient. We term as multicarrier every attribute value that involves more than one carrier individual. Otherwise the attribute value is termed as singlecarrier (e.g., every 'pneumonia'). Actually, 'asymptomatic hemophilia A' entails that patient's relatives (e.g., any parent, son, brother, sister) have with high probability the same disease, more or less seriously. All 'dominant autosomal diseases' (e.g., Huntington's disease, Neurofibromatosis, a form of hypercholesterolemia and a form of nanism) and 'autosomal recessive disorders' (e.g., thalassemias) are other examples of multicarrier diseases.
A privacy-aware socio-sanitary system might be unfair towards individuals having a crucial relationship with the information donor but who may even not know that they have a particular genetic trait.
INFORMED FAIR CONSENT
We say that a consent is fair if it does not potentially compromise the privacy of others. The Fair Consent Principle statement we are going to propose is an extension of the concise Informed Consent Principle in Section 2.
'Personal information that has been collected should have the consent of the information donor and should not compromise privacy of whoever is potentially identifiable by the donor's consent.'
Notice that 'potentially identifiable by the donor's consent' is a difficult to quantify privacy threat. Nonetheless, it increases with increasing ubiquitous embedded computing, cloud computing. Once biological scientific results (as DNA) have added the biological family notion to the traditional legal family, a patient with a multicarrier disease may not know to have genetic relatives (e.g., biological fathers, biological parents) somewhere and thus may give informed consent to publish personal genetic data. In most cases, it may be impossible or impractical to obtain consent from them. Such relatives could be more and more easily identifiable once the patient's data can be linked to data in remote sites gathered from embedded devices. Moreover, seeking information about the medical history of a biological family may reveal information that was not intended for disclosure about unexpected individuals.
FAIR PERSONALIZED PRIVACY
National and international privacy legislation norms require implementable notions in order to be effective. Often principles are not a practice also because of implementation difficulties. The question whether the Fair Consent Principle can be effective in particular for what concerns the tradeoff between privacy protection and released data utility naturally arises. A strong privacy preservation may determine that released data become useless. Actually, whereas adopting the strongest security technology which is at disposal is never dangerous (although it may have a high technological cost), the strongest privacy technological solution might be dangerous in some contexts. The contrast between privacy protection and data utility has received much attention in the last years. An acceptable trade-off between releasing information while preserving privacy is a major issue (Fung et al., 2010) . Since medico-sanitary data accept a low information loss level, hiding or removing information from them may dramatically compromise their utility. To support data-mining tasks and to protect sensitive personal information, some well known anonymity methods have been proposed. Namely, suppression of Identifiers has been combined with generalization or perturbation on Quasi-identifiers. Specifically, generalizations (e.g., k-anonymity, ldiversity, t-closeness) essentially consist of grouping data into broader classes; data perturbation essentially consists of adding noise (e.g., numerical rounding, attribute random swapping, partially suppressing records). Several well-known papers have been published on merits and drawbacks of those privacy protection methods. In (Brickell, 2008) it is claimed, on the basis of some experimental results, that even a modest enhancing in privacy protection determines almost complete loss of data mining utility.
In the multicarrier attribute case, a social and ethical criterion may underline that the consent of just one element of a group of individuals is not enough. We here follow neither of the two extreme positions, namely on the one hand the impractical personalized policy which could force us to complete the obtained consent with that of all the remaining components of the group, and on the other hand the analogously strict criterion which could force us to suppress a record with a partial consent. Other solutions are possible which may be preferred taking into account the application domains. Two of them are: 1) generalizing also on Sensitive Attributes under a taxonomy; 2) releasing the actual sensitive values together with the maximal anonymity for all Quasi-identifiers.
We are going to shortly discuss such potential solutions.
1)
If generalizations occur inside a taxonomy, we claim that real-world taxonomies in use have to be preferred. In the sanitary context, Medical Taxonomies are more or less comprehensive hierarchical medical coding systems which encode disease diagnoses into medical codes. Such a coding helps accessing to health records according to diagnoses, procedures for use in clinical care, health statistics reporting, research and education. A review of medical coding systems is in (Cimino, 1996) . No accepted standard exists for coding patient information. Major coding schemes are usually compatible with the archetypal medical coding system, namely ICD (International Classification of Disease). Since medical knowledge grows with new terms to add and old ones to discard, ICD is revised at year intervals. ICD-9 and ICD-10 are the ninth and tenth editions, respectively. ICD-10-CM (Clinical Modification of ICD-10), will replace ICD-9-CM on October 2013.
After the Health Insurance Portability and Accountability Act of 1996 (HIPAA), using the Health Care Common Procedure Coding System (HCPCS) became mandatory. Only the governing body responsible for maintaining the code set has the authority to provide advice on how to apply a code set.
As in Figure 1 , medical codes are numbers such that, for a finer granularity, digits are added in decimal place. Usually, decimal from .0 to .7 codes a more specific core term, .8 codes another category and .9 'unspecified'. In any case, a label is composed of the diagnosis term and of its medical code.
In Table 3 , ICD-9-CM medical codes replace their corresponding diseases. The codes for blood diseases can be seen in Figure 1 . The codes in records n.4, n.7 and n.9 have been generalized by replacing them with the most general code in Figure 1 . A drawback for sensitive attribute generalization is that it may determine an information loss that might turns out as unacceptable for data mining applications in some contexts. Moreover, generalizing sensitive attributes gives rise to the so called 'divergence' drawback. Specifically, as 'Coagulation Defects' includes several variants of blood disease, the certain knowledge about 'asymptomatic hemophilia A' becomes an uncertain knowledge about all diseases concerning blood coagulation. The gain in privacy protection is questionable. Nevertheless, such a solution might be preferred in contexts where uncertainty is acceptable for the data mining to be performed.
2)
Releasing the true sensitive attribute values and maximal anonymity for all the Quasi-identifiers could balance each other, as in Table 4 , under the assumed taxonomies for Sex and Age, and an analogous taxonomy for Zipcode. The intended aim of such a solution (may be interesting for some statistical analysis) was to make anonymous individuals with a multicarrier disease. The fact that complete anonymity is never yielded here may be tolerated because the assumed attacker is semi-honest.
RELATED WORK
Problems related to the informed consent have been underlined especially for care delivering, as in (Applebaum et al., 1987) . In the personalized privacy approach, generalizations under taxonomies often utilize simple ad hoc defined taxonomies, as in (Poovammal and Ponnavaikko, 2009) , where patients are allowed to choose among three alternative options for data release (the true diagnosis, a less informative diagnosis, no diagnosis at all). In (Bertino et al., 2005) outsourced medical data are addressed for the identity disclosure at a non-personalized privacy setting, together with data ownership protection via digital watermarking. The binning algorithms there proposed for the information disclosure control on Quasi-identifiers exploit a k-anonymity that does not require all generalization nodes to be at the same level in domain hierarchy trees representing taxonomies. The information loss constraint is quantified as usage metrics for a maximal allowable information loss. The multicarrier notion formulated in this paper is in (Chen et al., 2007) as a kind of external knowledge exploitable to discover sensitive data. Multi-owner privacy in (Li et al., 2010) and (Ren et al., 2011) and the multiparty privacy in, e.g., (Chen and Liu, 2009) )cover privacy problems which arise when some parties jointly are actively involved in a computation task, usually on the web.
CONCLUSIONS
The claim of this paper was to discuss the informed consent for data release and to point out a social threat that may stem from some granted patient consents. A fair consent is proposed to enhance personalized privacy toward a fair personalized privacy, hopefully improving privacy protection in social services. If a privacy-aware system implements fair personalization, privacy assurance (that provides how much a party can trust a system as able to protect privacy) may be enhanced. Patients who have not enough trust in a health system's privacy protection capability might suppress some relevant information. This could lead to a poor care treatment and to an increased sanitary risk (e.g., if an infectious disease is omitted). We also claim that several implementations of the Fair Consent Principle are possible and that an acceptable tradeoff between privacy protection and data utility can be yield if implementations are tailored to the data mining requests.
Further Work. This work, as a position paper, leaves room for some developments, as for instance specific implementations, models and policies for a fair privacy. Let us mention just two scenarios. The one concerns fair consent policies for health and rights of donor-conceived children in an ubiquitous computing environment with weak control on the gathered data (due to possible data mining in countries with different laws). Such policies involve both technology and law, technology for effective solutions and for resilience to malicious managements. Another scenario concerns the fair consent model for so called dynamic data sets gathered from patients monitored via embedded devices during also their movements.
